CNTB Connect Biopharma Holdings Ltd
Company Analysis
Latest News
🟢 Connect Biopharma is trading 7.22% up in pre-market with no catalyst identified
Connect Biopharma is trading 7.22% up at $2.19, with no new company-specific catalyst identified for September 14, 2026. - Management’s September 15 H.C....
🔴 Connect Biopharma is trading 5% down today with no identified company-specific catalyst
Connect Biopharma is trading 5.1% down at $1.96; no credible company-specific announcement dated September 11, 2026 was identified. - The latest disclosed...
🟢 Connect Biopharma is trading 5.74% up today ahead of Seabreeze STAT topline results
Connect Biopharma is trading 5.74% up at $2.02 as investors continue positioning ahead of expected topline results from its Phase 2 Seabreeze STAT asthma...
Connect Biopharma Jumps 7% on Data Hopes — But Can a $130 Million Company Really Crack the Acute Asthma Market?
Shares shifted as Connect Biopharma (CNTB) climbed 7.1% to $1.97 on a down day for U.S. markets, signaling that the move is company-specific, not a rising...
🟢 Connect Biopharma is trading 7% up today ahead of expected September 2026 Seabreeze topline results
Connect Biopharma is trading 7.07% up at $1.97, with investor positioning ahead of expected September 2026 topline results from the Phase 2 Seabreeze STAT...
Connect Biopharma Nears Phase 2 Rademikibart Data for Asthma and COPD
Connect Biopharma expects topline results from its Phase 2 Seabreeze STAT studies in September 2026. The trials evaluate lead candidate rademikibart for...
🟢 Connect Biopharma is trading 10.61% up in pre-market; no clear catalyst identified
Connect Biopharma is trading 10.61% up at $2.04, with no clear company-specific catalyst identified for September 8, 2026. - Phase 2 Seabreeze STAT asthma and...
🟢 Connect Biopharma is trading 9.61% up in pre-market with no clear catalyst identified
Connect Biopharma is trading at $2.02, up 9.61%, in pre-market with no clear company-specific catalyst identified. - No new company-specific announcement...
🟢 Connect Biopharma is trading 5.34% up in after-hours trading ahead of expected September Phase 2 results
Connect Biopharma is trading $1.94 (+5.34%) after-hours amid possible investor positioning ahead of expected September results from two Phase 2 Seabreeze...
🔴 Connect Biopharma is trading 6% down today
Connect Biopharma is trading at $1.81, down 5.96%, with no clear company-specific catalyst identified for September 4, 2026. • Shares declined 30.07% on...
🟢 Connect Biopharma is trading 10.82% up in pre-market after plunging 30.07% during September 3 session
Connect Biopharma is trading $2.14, up 10.82% in pre-market after plunging 30.07% during the September 3, 2026 regular session. - No clear company-specific...
🟢 Connect Biopharma is trading 6.45% up in pre-market with no clear company-specific catalyst identified
Connect Biopharma is trading at $2.05, up 6.45% in pre-market after falling 30.07% during the September 3, 2026 regular session; no clear company-specific...
🟢 Connect Biopharma is trading 12.37% up in after-hours trading amid broader market gains
Connect Biopharma is trading at $2.17, up 12.37%, amid broader risk-on sentiment. - Shares fell 30.07% during the September 3 regular session; no new...
🔴 Connect Biopharma is trading 10.51% down today with no company-specific explanation identified
Connect Biopharma is trading 10.51% down at $2.47 after two consecutive strong sessions, including a 16.95% gain on September 2; no new company-specific...
🔴 Connect Biopharma is trading 7.1% down today after two consecutive strong sessions
Connect Biopharma is trading 7.1% down at $2.57, following a pullback after two consecutive strong sessions. - The stock reached $2.76 on September 2. - No...
🟢 Connect Biopharma is trading 5% up today ahead of September Seabreeze results
Connect Biopharma is trading 5% up at $2.90, supported primarily by investor anticipation of September topline results from the Phase 2 Seabreeze STAT asthma...
🟢 Connect Biopharma is trading 5% up in pre-market amid expected September topline results
Connect Biopharma is trading 5.07% up now at $2.90 in pre-market trading, with ongoing interest possibly supported by expected September topline results; no...
🟢 Connect Biopharma is trading 10.2% up today on broad biotech-sector gains
Connect Biopharma is trading at $2.60 (+10.17%) alongside broader biotechnology strength, with no new company-specific announcement identified for September 2,...
🟢 Connect Biopharma is trading 6.4% up today on broad biotech-sector gains
Connect Biopharma is trading 6.4% up at $2.51, with the move appearing mainly sector-driven as biotech stocks gain broadly. - No new company-specific...
🟢 Connect Biopharma is trading 6.4% up today; no clear catalyst identified
Connect Biopharma is trading 6.4% up at $2.34, with no clear catalyst identified. - No new company-specific announcement was identified for September 1, 2026;...